Posted on October 28th, 2011 by
Another paused phase 3 trial aims to treat acute myeloid leukemia (AML) in the elderly. It is waiting for the chemotherapy drugs Cerubidine (daunorubicin), manufactured by Winthrop Pharmaceuticals, and Tarabine PFS (cytarabine), made by several companies, including Hospira. James Foran, a medical oncologist at the Mayo Clinic in Jacksonville, Florida, heads the study. The trial is his baby — he started working on it five years ago and was hoping to have preliminary data in 2013. “This is the sort of trial that can get me promoted to professor someday,” he says. “If it fails, I will have to go straight back to the drawing board.”
You must be logged-in to the site to post a comment.